Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022

  • GLO1197771
  • 121 Pages
  • May 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

In the last several years, global market of Pneumococcal Vaccine developed rapidly generally, while global production growth rate of Pneumococcal Vaccine experienced slight fluctuations due to patent validity. In 2016, global production of Pneumococcal Vaccine is nearly 126 million doses. The Revenue of Pneumococcal Vaccine is around 6768 M in 2016.

Scope of the Report:

This report focuses on the Pneumococcal Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Pfizer

GSK

MSD

Sanofipasteur

CDIBP

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

PPSV 23

PCV 7/13

PCV 10

Market Segment by Applications, can be divided into

Child

Adult

There are 15 Chapters to deeply display the global Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumococcal Vaccine, with sales, revenue, and price of Pneumococcal Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview 1

1.1 Pneumococcal Vaccine Introduction 1

1.2 Market Analysis by Type 3

1.2.1 PPSV 23 4

1.2.2 PCV 7/13 4

1.2.3 PCV 10 5

1.3 Market Analysis by Applications 6

1.3.1 Child 6

1.3.2 Adult 7

1.4 Market Analysis by Regions 8

1.4.1 North America (USA, Canada and Mexico) 8

1.4.2 Europe (Germany, France, UK, Russia and Italy) 11

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 16

1.4.4 South America 21

1.4.5 Middle East and Africa 24

1.5 Market Dynamics 28

1.5.1 Market Opportunities 28

1.5.2 Market Risk 28

1.5.3 Market Driving Force 29

2 Manufacturers Profiles 30

2.1 Pfizer 30

2.1.1 Business Overview 30

2.1.2 Pneumococcal Vaccine Picture 31

2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 31

2.2 GSK 31

2.2.1 Business Overview 31

2.2.2 Pneumococcal Vaccine Product Picture 32

2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 33

2.3 MSD 33

2.3.1 Business Overview 33

2.3.2 Pneumococcal Vaccine Product Picture 34

2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 35

2.4 Sanofipasteur 35

2.4.1 Business Overview 35

2.4.2 Pneumococcal Vaccine Product Picture 36

2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 36

2.5 CDIBP 37

2.5.1 Business Overview 37

2.5.2 Pneumococcal Vaccine Product Picture 38

2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 38

3 Global Pneumococcal Vaccine Market Competition, by Manufacturer 39

3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer 39

3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer 40

3.3 Market Concentration Rate 42

3.4 Market Competition Trend 42

4 Global Pneumococcal Vaccine Market Analysis by Regions 43

4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions 43

4.1.1 Global Pneumococcal Vaccine Sales by Regions (2012-2017) 44

4.1.2 Global Pneumococcal Vaccine Revenue by Regions (2012-2017) 45

4.2 North America Pneumococcal Vaccine Sales and Growth (2012-2017) 47

4.3 Europe Pneumococcal Vaccine Sales and Growth (2012-2017) 48

4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth (2012-2017) 49

4.5 South America Pneumococcal Vaccine Sales and Growth (2012-2017) 50

4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth (2012-2017) 51

5 North America Pneumococcal Vaccine by Countries 52

5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 52

5.1.1 North America Pneumococcal Vaccine Sales by Countries (2012-2017) 52

5.1.2 North America Pneumococcal Vaccine Revenue by Countries (2012-2017) 54

5.2 USA Pneumococcal Vaccine Sales and Growth (2012-2017) 56

5.3 Canada Pneumococcal Vaccine Sales and Growth (2012-2017) 57

5.4 Mexico Pneumococcal Vaccine Sales and Growth (2012-2017) 58

6 Europe Pneumococcal Vaccine by Countries 59

6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 59

6.1.1 Europe Pneumococcal Vaccine Sales by Countries (2012-2017) 59

6.1.2 Europe Pneumococcal Vaccine Revenue by Countries (2012-2017) 61

6.2 Germany Pneumococcal Vaccine Sales and Growth (2012-2017) 63

6.3 UK Pneumococcal Vaccine Sales and Growth (2012-2017) 64

6.4 France Pneumococcal Vaccine Sales and Growth (2012-2017) 64

6.5 Russia Pneumococcal Vaccine Sales and Growth (2012-2017) 65

6.6 Italy Pneumococcal Vaccine Sales and Growth (2012-2017) 65

7 Asia-Pacific Pneumococcal Vaccine by Countries 66

7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 66

7.1.1 Asia-Pacific Pneumococcal Vaccine Sales by Countries (2012-2017) 66

7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue by Countries (2012-2017) 68

7.2 China Pneumococcal Vaccine Sales and Growth (2012-2017) 70

7.3 Japan Pneumococcal Vaccine Sales and Growth (2012-2017) 71

7.4 Korea Pneumococcal Vaccine Sales and Growth (2012-2017) 72

7.5 India Pneumococcal Vaccine Sales and Growth (2012-2017) 73

7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth (2012-2017) 74

8 South America Pneumococcal Vaccine by Countries 75

8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 75

8.1.1 South America Pneumococcal Vaccine Sales by Countries (2012-2017) 75

8.1.2 South America Pneumococcal Vaccine Revenue by Countries (2012-2017) 77

8.2 Brazil Pneumococcal Vaccine Sales and Growth (2012-2017) 79

8.3 Argentina Pneumococcal Vaccine Sales and Growth (2012-2017) 80

8.4 Columbia Pneumococcal Vaccine Sales and Growth (2012-2017) 81

9 Middle East and Africa Pneumococcal Vaccine by Countries 82

9.1 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 82

9.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries (2012-2017) 82

9.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2012-2017) 84

9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth (2012-2017) 87

9.3 UAE Pneumococcal Vaccine Sales and Growth (2012-2017) 88

9.4 Egypt Pneumococcal Vaccine Sales and Growth (2012-2017) 89

9.5 Nigeria Pneumococcal Vaccine Sales and Growth (2012-2017) 90

9.6 South Africa Pneumococcal Vaccine Sales and Growth (2012-2017) 91

10 Global Pneumococcal Vaccine Market Segment by Type 92

10.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2012-2017) 92

10.1.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2012-2017) 92

10.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017) 92

10.2 PPSV 23 Sales Growth and Price 93

10.2.1 Global PPSV 23 Sales Growth (2012-2017) 93

10.2.2 Global PPSV 23 Price (2012-2017) 94

10.3 PCV 7/13 Sales Growth and Price 95

10.3.1 Global PCV 7/13 Sales Growth (2012-2017) 95

10.3.2 Global PCV 7/13 Price (2012-2017) 96

10.4 PCV 10 Sales Growth and Price 97

10.4.1 Global PCV 10 Sales Growth (2012-2017) 97

10.4.2 Global PCV 10 Price (2012-2017) 98

11 Global Pneumococcal Vaccine Market Segment by Application 99

11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2012-2017) 99

11.2 Child Sales Growth (2012-2017) 100

11.3 Adult Sales Growth (2012-2017) 100

12 Pneumococcal Vaccine Market Forecast (2017-2022) 101

12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022) 101

12.2 Pneumococcal Vaccine Market Forecast by Regions (2017-2022) 102

12.2.1 North America Pneumococcal Vaccine Market Forecast (2017-2022) 103

12.2.2 Europe Pneumococcal Vaccine Market Forecast (2017-2022) 104

12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2017-2022) 105

12.2.4 South America Pneumococcal Vaccine Market Forecast (2017-2022) 106

12.2.5 Middle East and Africa Pneumococcal Vaccine Market Forecast (2017-2022) 107

12.3 Pneumococcal Vaccine Market Forecast by Type (2017-2022) 107

12.4 Pneumococcal Vaccine Market Forecast by Application (2017-2022) 108

13 Sales Channel, Distributors, Traders and Dealers 109

13.1 Sales Channel 109

13.2 Distributors, Traders and Dealers 110

14 Research Findings and Conclusion 112

15 Appendix 113

15.1 Methodology 113

15.2 Analyst Introduction ??!??????

15.3 Data Source 114List of Tables and Figures

Figure Pneumococcal Vaccine Picture 1

Figure Specifications of PCV 13 2

Figure Specifications of PCV 10 2

Figure Specifications of PPSV 23 2

Figure Global Sales Market Share of Pneumococcal Vaccine by Types in 2016 3

Table Types of Pneumococcal Vaccine 3

Table Pneumococcal Vaccine Types for Major Manufacturers in 2016 3

Figure PPSV 23 Picture 4

Figure PCV 7/13 Picture 5

Figure PCV 10 Picture 5

Figure Pneumococcal Vaccine Sales Market Share by Applications in 2016 6

Table Applications of Pneumococcal Vaccine 6

Figure Child Picture 7

Figure Adult Picture 7

Figure USA Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 8

Figure Canada Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 9

Figure Mexico Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 10

Figure Germany Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 11

Figure France Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 12

Figure UK Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 13

Figure Russia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 14

Figure Italy Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 15

Figure China Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 16

Figure Japan Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 17

Figure Korea Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 18

Figure India Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 19

Figure Southeast Asia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 20

Figure Brazil Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 21

Figure Argentina Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 22

Figure Columbia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 23

Figure Saudi Arabia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 24

Figure UAE Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 25

Figure Egypt Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 26

Figure Nigeria Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 27

Figure South Africa Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 28

Table Market Opportunities 28

Table Market Risk 28

Table Market Driving Force 29

Table Pfizer Basic Information 30

Figure Pneumococcal Vaccine Picture of Pfizer 31

Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 31

Table GSK Basic Information 31

Figure Pneumococcal Vaccine Product Picture of GSK 32

Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 33

Table MSD Basic Information 33

Figure Pneumococcal Vaccine Product Picture of MSD 34

Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 35

Table Sanofipasteur Basic Information 35

Figure Pneumococcal Vaccine Product Picture of Sanofipasteur 36

Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 36

Table CDIBP Basic Information 37

Figure Pneumococcal Vaccine Product Picture of CDIBP 38

Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 38

Table Global Pneumococcal Vaccine Sales (K Doses) by Manufacturer (2016-2017) 39

Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016 39

Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017 40

Table Global Pneumococcal Vaccine Revenue (M ) by Manufacturer (2016-2017) 40

Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016 41

Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017 41

Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share 42

Figure Global Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 43

Figure Global Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 44

Table Global Pneumococcal Vaccine Sales (K Doses) by Regions (2012-2017) 44

Table Global Pneumococcal Vaccine Sales Market Share by Regions (2012-2017) 44

Table Global Pneumococcal Vaccine Revenue (M ) by Regions (2012-2017) 45

Table Global Pneumococcal Vaccine Revenue Market Share by Regions in 2012 45

Table Global Pneumococcal Vaccine Revenue Market Share by Regions in 2016 46

Figure North America Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 47

Figure Europe Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 48

Figure Asia-Pacific Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 49

Figure South America Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 50

Figure Middle East and Africa Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 51

Figure North America Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 52

Table North America Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 52

Table North America Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 53

Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2012 53

Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2016 54

Table North America Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 54

Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 54

Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2012 55

Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2016 55

Figure USA Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 56

Figure Canada Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 57

Figure Mexico Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 58

Figure Europe Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 59

Table Europe Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 59

Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 60

Figure Europe Pneumococcal Vaccine Sales Market Share by Countries in 2012 60

Figure Europe Pneumococcal Vaccine Sales Market Share by Countries in 2016 61

Table Europe Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 61

Table Europe Pneumococcal Vaccine Revenue Share by Countries (2012-2017) 61

Table Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2012 62

Table Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2016 63

Figure Germany Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 63

Figure UK Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 64

Figure France Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 64

Figure Russia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 65

Figure Italy Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 65

Figure Asia-Pacific Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 66

Table Asia-Pacific Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 66

Table Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 67

Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries in 2012 67

Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries in 2016 68

Table Asia-Pacific Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 68

Table Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 68

Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries in 2012 69

Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries in 2016 70

Figure China Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 70

Figure Japan Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 71

Figure Korea Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 72

Figure India Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 73

Figure Southeast Asia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 74

Figure South America Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 75

Table South America Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 75

Table South America Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 76

Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2012 76

Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2016 77

Table South America Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 77

Table South America Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 77

Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2012 78

Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2016 79

Figure Brazil Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 79

Figure Argentina Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 80

Figure Columbia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 81

Figure Middle East and Africa Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 82

Table Middle East and Africa Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 82

Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 83

Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2012 83

Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2016 84

Table Middle East and Africa Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 84

Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 84

Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2012 85

Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2016 86

Figure Saudi Arabia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 87

Figure UAE Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 88

Figure Egypt Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 89

Figure Nigeria Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 90

Figure South Africa Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 91

Table Global Pneumococcal Vaccine Sales (K Doses) by Type (2012-2017) 92

Table Global Pneumococcal Vaccine Sales Share by Type (2012-2017) 92

Table Global Pneumococcal Vaccine Revenue (M ) by Type (2012-2017) 92

Table Global Pneumococcal Vaccine Revenue Share by Type (2012-2017) 93

Figure Global PPSV 23 Sales Growth (2012-2017) 93

Figure Global PPSV 23 Price (/Dose) (2012-2017) 94

Figure Global PCV 7/13 Sales Growth (2012-2017) 95

Figure Global PCV 7/13 Price (/Dose) (2012-2017) 96

Figure Global PCV 10 Sales Growth (2012-2017) 97

Figure Global PCV 10 Price (/Dose) (2012-2017) 98

Table Global Pneumococcal Vaccine Sales (K Doses) by Application (2012-2017) 99

Table Global Pneumococcal Vaccine Sales Share by Application (2012-2017) 99

Figure Global Child Sales Growth (2012-2017) 100

Figure Global Adult Sales Growth (2012-2017) 100

Figure Global Pneumococcal Vaccine Sales (K Doses) and Growth Rate (2017 -2022) 101

Figure Global Pneumococcal Vaccine Revenue (M ) and Growth Rate (2017 -2022) 102

Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Regions (2017-2022) 102

Table Global Pneumococcal Vaccine Market Share Forecast by Regions (2017-2022) 102

Figure North America Sales Pneumococcal Vaccine Market Forecast (2017-2022) 103

Figure Europe Sales Pneumococcal Vaccine Market Forecast (2017-2022) 104

Figure Asia-Pacific Sales Pneumococcal Vaccine Market Forecast (2017-2022) 105

Figure South America Sales Pneumococcal Vaccine Market Forecast (2017-2022) 106

Figure Middle East and Africa Sales Pneumococcal Vaccine Market Forecast (2017-2022) 107

Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Type (2017-2022) 107

Table Global Pneumococcal Vaccine Market Share Forecast by Type (2017-2022) 107

Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Application (2017-2022) 108

Table Global Pneumococcal Vaccine Market Share Forecast by Application (2017-2022) 108

Table Distributors/Traders/ Dealers List 110

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370